Existing electrical neurostimulation therapies, such as Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), and Vagal Nerve Stimulation (VNS), often require highly invasive procedures, implanted batteries, and physician intervention for optimal treatment adjustment. These limitations restrict broader usage and can lead to complications.

Cenexum is developing a wirelessly powered neural interfacing technology that enables bi-directional communication with nerve tissue through a miniature, intelligent implantable device. This device facilitates bio-inspired data processing and stimulation in a closed-loop system, allowing for personalized adjustment of neurostimulation. Wireless communication between the microscale implant and an external unit eliminates the need for implanted batteries, reducing surgical complexity and potential complications. The technology aims to provide safe, effective, and convenient treatment options for neurological and psychiatric disorders.

Miniatured implantable device enabling bio-inspired data processing and stimulation in a closed loop

Wireless communication via mild electrical impulses between microscale-implant device and external unit

Wirelessly powered implantable device eliminating the need for implanted batteries

Potential for networking multiple devices to integrate data from various parts of the central and peripheral nervous system

AI and ML-driven data processing for personalized neurostimulation adjustments

Suitable for implantation at the core location of the disease to treat

The primary target audience includes patients with neurological and psychiatric disorders, such as chronic pain, depression, movement disorders, Parkinson’s disease, Alzheimer’s disease, and epilepsy, as well as neurosurgeons and medical professionals specializing in neuromodulation therapies.